JPRN-UMIN000044616
Recruiting
未知
A feasibility study of Risk-Reducing Salpingo-Oophorectomy based on hereditary breast and ovarian cancer syndrome -associated gene mutations - A feasibility study of Risk-Reducing Salpingo-Oophorectomy based on hereditary breast and ovarian cancer syndrome -associated gene mutations
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Patients with mutations in BRCA1/2, BRIP, RAD51C and RAD51D genes
- Sponsor
- Kyoto University
- Enrollment
- 50
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •(1\) Patients who do not have sufficient judgment, are unconscious, or require consideration of the name of the disease (2\) Patients with serious life\-threatening complications. (3\) Patients who are judged by the principal investigator to be inappropriate for inclusion in the study. (4\) Patients whose consent has not been obtained or who have requested to withdraw their consent. (5\) Any other patient whom the principal investigator or sub\-investigator deems inappropriate to conduct this research.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Feasibility study of risk reducing salpingo-oophorectomy for BRCA1/2 mutation carrierHereditary breast ovarian cancer syndromeJPRN-UMIN000033384Yamaguchi University Hospital8
Recruiting
Not Applicable
Study on the effect of Risk-Reducing Salpingo-oophorectomy in hereditary breast and ovarian cancerHereditary breast and ovarian caccerJPRN-UMIN000023187Asahikawa Medical University10
Unknown
Not Applicable
Safety and efficacy study of Risk-Reducing salpingo-oopholectomy in BRCA1/2 mutant carriersJPRN-UMIN000015021Okayama university hospital20
Recruiting
Not Applicable
Establishment of risk-reducing salpingo-oohorectomy for hereditary breast and ovarian syndromeovarian cancer tubal cancerJPRN-UMIN000024515Fujita Health University, Gynecology and Obstetrics5
Recruiting
Not Applicable
Feasibility assessment of the prophylactic Use of AneuFix at the time of EVAR implantatioEndoleakLeak10002363NL-OMON54373TripleMed B.V.5